Live·Open questions in longevity research
Hypothesis Universe
Omega Point · Hypothesis

removal may limit damage from shielded against its natural

Suppressing may restore removal of -bearing despite blocked . Benefit without fewer active- , or persistent -size dependence after detachment, would reject the proposed mechanism.

Stage of verification

  1. Hypothesis published2026-09-30
  2. Indirect evidenceAssessed at 4 of 10
  3. Direct testAwaited

Map of the hypothesis

Hover over an icon or tap it to see its name.

Where in the body

Main connectionImmune system

Ageing mechanism

Main connectionChronic inflammation

Direction

Lens

Puts the cause at the boundaries: the membranes, junctions and barriers that keep compartments apart.Interfaces and barriers

Kind of knowledge gap

The question is designed to try to disprove the leading explanation.Adversarial gap

A double ring marks the main placement where a group contains several values.

Goal
Устойчивость восстановления к закреплению повреждённого состояния
Competing hypotheses
4
Published
2026-09-30
As a hypothesis
8 / 10Clarity of mechanism
8 / 10Few extra conditions
10 / 10Completeness of the answer
5 / 10Novelty of the idea
9 / 10Few new entities
8 / 10Decisive experiment
4 / 10Silver-bullet potential
4 / 10Support from research
Poster: Vesicle removal limits elastase damage
PosterOpen the sheet full size2026-09-30

Target map

Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.

  1. Enzyme

    A protein-cleaving associated with

    Where this hypothesis actsOn small , accessible to tissue proteins but shielded from

    Hypotheses on this target 1
    Neutrophil elastaseInhibition. Hypotheses on this target 11Activation. Hypotheses on this target 0Lower level. Hypotheses on this target 0Higher level. Hypotheses on this target 0Replacement. Hypotheses on this target 0Protection from degradation. Hypotheses on this target 0Cofactor removal. Hypotheses on this target 0Synthesis suppression. Hypotheses on this target 0Function preservation. Hypotheses on this target 0
    • Inhibition1
    • Activation
    • Lower level
    • Higher level
    • Replacement
    • Protection from degradation
    • Cofactor removal
    • Synthesis suppression
    • Function preservation

    What is proposed

    Inhibition

    Inhibit activity on

    With whatSmall molecule

    HowUse a small to overcome the proposed steric barrier; compare with equal activity against free

    Possible result

    Possible improvement in tissue function and reduction in residual functional deficit SPV_6

    From the recordПри одинаковой активности против свободной эластазы малый ингибитор подавляет везикулярную протеазу и восстанавливает функции эффективнее крупного ингибитора.

  2. Receptor or channel

    receptor

    A receptor whose activity can be suppressed

    Where this hypothesis actsDuring blockade of whole- engulfment

    Hypotheses on this target 5
    EP2 receptorLower level. Hypotheses on this target 0Higher level. Hypotheses on this target 0Blockade. Hypotheses on this target 55Agonism. Hypotheses on this target 0Desensitisation. Hypotheses on this target 0Function restoration. Hypotheses on this target 0Function preservation. Hypotheses on this target 0
    • Lower level
    • Higher level
    • Blockade5
    • Agonism
    • Desensitisation
    • Function restoration
    • Function preservation

    What is proposed

    Blockade

    Suppress activity

    With whatNot stated in the record

    HowNot stated in the record

    Possible result

    Possible restoration of by and retention of benefits

    From the recordПодавление EP2 предположительно восстанавливает захват этих везикул макрофагами, даже когда поглощение целых нейтрофилов остаётся заблокированным.

  3. Immune response

    The and removal of

    Where this hypothesis acts of carrying active while whole- engulfment is blocked

    Hypotheses on this target 1
    Extracellular vesicle clearanceInhibition. Hypotheses on this target 0Activation. Hypotheses on this target 0Function preservation. Hypotheses on this target 0Clearance restoration. Hypotheses on this target 11Immunosuppression. Hypotheses on this target 0Feedback restoration. Hypotheses on this target 0Rhythm restoration. Hypotheses on this target 0
    • Inhibition
    • Activation
    • Function preservation
    • Clearance restoration1
    • Immunosuppression
    • Feedback restoration
    • Rhythm restoration

    What is proposed

    Clearance restoration

    Restore of -bearing

    With whatNot stated in the record

    HowSuppress to restore of these while maintaining blockade of whole- engulfment

    Possible result

    Possible reduction in residual functional deficit SPV_6 through removal of carriers

    From the recordУдаление её носителей должно уменьшать остаточный функциональный дефицит SPV_6.

All targets of the lab

Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.

MoleculesAntibodies. Hypotheses on this target 3AntibodiesInterleukin-1α. Hypotheses on this target 3Interleukin-1αAmyloid seeds. Hypotheses on this target 2Amyloid seedsATP. Hypotheses on this target 2ATPCGRP. Hypotheses on this target 2CGRPHyaluronan. Hypotheses on this target 2HyaluronanInterleukin-1 receptor antagonist. Hypotheses on this target 2Interleukin-1 receptor antagonistInterleukin-6. Hypotheses on this target 2Interleukin-6Potassium. Hypotheses on this target 2PotassiumSpecialized pro-resolving lipid mediators. Hypotheses on this target 2Specialized pro-resolving lipid mediatorsAmmonia. Hypotheses on this target 1AmmoniaAntimicrobial peptides. Hypotheses on this target 1Antimicrobial peptidesBlood carbon dioxide. Hypotheses on this target 1Blood carbon dioxideBMP. Hypotheses on this target 1BMPCholesterol crystals. Hypotheses on this target 1Cholesterol crystalsCorticosterone. Hypotheses on this target 1CorticosteroneCryptic collagen ligands. Hypotheses on this target 1Cryptic collagen ligandsDKK1. Hypotheses on this target 1DKK1Double-stranded RNA. Hypotheses on this target 1Double-stranded RNAExtracellular electrolytes. Hypotheses on this target 1Extracellular electrolytesExtracellular histones. Hypotheses on this target 1Extracellular histonesFas ligand. Hypotheses on this target 1Fas ligandGlutamine. Hypotheses on this target 1GlutamineGlutathione. Hypotheses on this target 1GlutathioneHeavy chain–hyaluronan complexes. Hypotheses on this target 1Heavy chain–hyaluronan complexesHistamine. Hypotheses on this target 1HistamineInterleukin-10. Hypotheses on this target 1Interleukin-10Interleukin-22. Hypotheses on this target 1Interleukin-22Lipid A. Hypotheses on this target 1Lipid ALipid hydroperoxides. Hypotheses on this target 1Lipid hydroperoxidesM3 receptor autoantibodies. Hypotheses on this target 1M3 receptor autoantibodiesNAD+. Hypotheses on this target 1NAD+NKG2D ligands. Hypotheses on this target 1NKG2D ligandsNoggin. Hypotheses on this target 1NogginOxygen. Hypotheses on this target 1OxygenPeroxide. Hypotheses on this target 1PeroxidePGP-family peptides. Hypotheses on this target 1PGP-family peptidesPhenol-soluble modulins alpha (PSMα). Hypotheses on this target 1Phenol-soluble modulins alpha (PSMα)Phosphatidylserine. Hypotheses on this target 1PhosphatidylserinePlatelet-activating anti-PF4 immunoglobulin. Hypotheses on this target 1Platelet-activating anti-PF4 immunoglobulinProstaglandin E2. Hypotheses on this target 1Prostaglandin E2RNA–DNA hybrids. Hypotheses on this target 1RNA–DNA hybridsSenescent-cell secretions. Hypotheses on this target 1Senescent-cell secretionsSmall RNAs. Hypotheses on this target 1Small RNAsSoluble BCMA. Hypotheses on this target 1Soluble BCMAStratum corneum lipids. Hypotheses on this target 1Stratum corneum lipidsTacrolimus. Hypotheses on this target 1TacrolimusTGF-β1. Hypotheses on this target 1TGF-β1Tissue-binding antibodies. Hypotheses on this target 1Tissue-binding antibodiesTryptophan. Hypotheses on this target 1TryptophanTumstatin. Hypotheses on this target 1TumstatinVIP. Hypotheses on this target 1VIPWNT. Hypotheses on this target 1WNT
GenesRetroelements. Hypotheses on this target 3RetroelementsAcquired nuclear DNA. Hypotheses on this target 1Acquired nuclear DNAAntimicrobial protein coding sequences. Hypotheses on this target 1Antimicrobial protein coding sequencesExtrachromosomal DNA. Hypotheses on this target 1Extrachromosomal DNAHerpes simplex virus genomes. Hypotheses on this target 1Herpes simplex virus genomesHLA-II expression. Hypotheses on this target 1HLA-II expressionHormone-response regulatory variant combinations. Hypotheses on this target 1Hormone-response regulatory variant combinationsIFT88. Hypotheses on this target 1IFT88IRF4 half-site CpG methylation at the TGFB1 enhancer. Hypotheses on this target 1IRF4 half-site CpG methylation at the TGFB1 enhancerUV photolesions. Hypotheses on this target 1UV photolesions
Enzymes and receptorsProteases. Hypotheses on this target 7ProteasesGLS1. Hypotheses on this target 5GLS1YAP. Hypotheses on this target 5YAPmTOR. Hypotheses on this target 4mTORERK. Hypotheses on this target 3ERKFAK. Hypotheses on this target 2FAKGlutamine synthetase. Hypotheses on this target 2Glutamine synthetasemTORC1. Hypotheses on this target 2mTORC1Myosin. Hypotheses on this target 2MyosinNK1 receptor. Hypotheses on this target 2NK1 receptorp300. Hypotheses on this target 2p30012-lipoxygenase. Hypotheses on this target 112-lipoxygenaseAcid sphingomyelinase. Hypotheses on this target 1Acid sphingomyelinaseACOD1. Hypotheses on this target 1ACOD1Acyloxyacyl hydrolase. Hypotheses on this target 1Acyloxyacyl hydrolaseADAR1. Hypotheses on this target 1ADAR1AKT. Hypotheses on this target 1AKTAlpha-adrenergic receptors. Hypotheses on this target 1Alpha-adrenergic receptorsAMPK. Hypotheses on this target 1AMPKAntiproteases. Hypotheses on this target 1AntiproteasesApoptotic caspases. Hypotheses on this target 1Apoptotic caspasesβ-arrestin-2. Hypotheses on this target 1β-arrestin-2CAD. Hypotheses on this target 1CADCatalase. Hypotheses on this target 1CatalaseCathepsins. Hypotheses on this target 1CathepsinsCD1a. Hypotheses on this target 1CD1aCD40. Hypotheses on this target 1CD40CD45. Hypotheses on this target 1CD45CD47. Hypotheses on this target 1CD47Collagen IV. Hypotheses on this target 1Collagen IVCollagen VII. Hypotheses on this target 1Collagen VIIDermal collagen I and III triple helices. Hypotheses on this target 1Dermal collagen I and III triple helicesDNA polymerase theta. Hypotheses on this target 1DNA polymerase thetaEGFR. Hypotheses on this target 1EGFReIF2α. Hypotheses on this target 1eIF2αExecutioner caspases. Hypotheses on this target 1Executioner caspasesFactor XIII. Hypotheses on this target 1Factor XIIIFcγRIIa. Hypotheses on this target 1FcγRIIaFibrin. Hypotheses on this target 1FibrinFibronectin. Hypotheses on this target 1FibronectinFilamin C. Hypotheses on this target 1Filamin CFKBP12. Hypotheses on this target 1FKBP12FPR2/ALX receptor. Hypotheses on this target 1FPR2/ALX receptorβ-glucocerebrosidase. Hypotheses on this target 1β-glucocerebrosidaseGlucose-6-phosphate dehydrogenase. Hypotheses on this target 1Glucose-6-phosphate dehydrogenaseHCMV Fc-binding proteins. Hypotheses on this target 1HCMV Fc-binding proteinsHistones. Hypotheses on this target 1HistonesHsp70. Hypotheses on this target 1Hsp70HSPB1. Hypotheses on this target 1HSPB1Hyaluronan synthase 2. Hypotheses on this target 1Hyaluronan synthase 2Interleukin-10 receptor. Hypotheses on this target 1Interleukin-10 receptorIntestinal alkaline phosphatase. Hypotheses on this target 1Intestinal alkaline phosphataseKCC2. Hypotheses on this target 1KCC2LOX. Hypotheses on this target 1LOXM3 muscarinic receptor. Hypotheses on this target 1M3 muscarinic receptorMast-cell chymase. Hypotheses on this target 1Mast-cell chymaseMetabolic enzymes. Hypotheses on this target 1Metabolic enzymesMYC. Hypotheses on this target 1MYCMyeloperoxidase. Hypotheses on this target 1MyeloperoxidaseN-homocysteinylated circulating fibrinogen. Hypotheses on this target 1N-homocysteinylated circulating fibrinogenNitric oxide synthase. Hypotheses on this target 1Nitric oxide synthaseNK3 receptor. Hypotheses on this target 1NK3 receptorNKG2D receptor. Hypotheses on this target 1NKG2D receptorNOTUM. Hypotheses on this target 1NOTUMORF2. Hypotheses on this target 1ORF2PAR1. Hypotheses on this target 1PAR1PCMT1. Hypotheses on this target 1PCMT1PD-1. Hypotheses on this target 1PD-1PD-L1. Hypotheses on this target 1PD-L1Peptide–MHC complexes. Hypotheses on this target 1Peptide–MHC complexesPhosphofructokinase. Hypotheses on this target 1PhosphofructokinasePIEZO1. Hypotheses on this target 1PIEZO1Prostaglandin E2 receptors. Hypotheses on this target 1Prostaglandin E2 receptorsRibosomes. Hypotheses on this target 1RibosomesRNase H1. Hypotheses on this target 1RNase H1SIRT6. Hypotheses on this target 1SIRT6TIM-4. Hypotheses on this target 1TIM-4TLR2. Hypotheses on this target 1TLR2TRPV4. Hypotheses on this target 1TRPV4TSG-6. Hypotheses on this target 1TSG-6V8 protease. Hypotheses on this target 1V8 proteaseZAKα. Hypotheses on this target 1ZAKαEP2 receptor. Hypotheses on this target 5EP2 receptorNeutrophil elastase. Hypotheses on this target 1Neutrophil elastase
CellsSenescent fibroblasts. Hypotheses on this target 7Senescent fibroblastsSenescent cells. Hypotheses on this target 4Senescent cellsOvarian somatic cells. Hypotheses on this target 3Ovarian somatic cellsT cells. Hypotheses on this target 3T cellsCooperating dangerous cells in breast tissue. Hypotheses on this target 2Cooperating dangerous cells in breast tissueMacrophages. Hypotheses on this target 2MacrophagesSenescent stromal cells. Hypotheses on this target 2Senescent stromal cellsAdrenal zona fasciculata cells. Hypotheses on this target 1Adrenal zona fasciculata cellsAntigen-presenting cells. Hypotheses on this target 1Antigen-presenting cellsAPC-altered cells. Hypotheses on this target 1APC-altered cellsBasal cells. Hypotheses on this target 1Basal cellsCapillary mural cells. Hypotheses on this target 1Capillary mural cellsCD1a-reactive T cells. Hypotheses on this target 1CD1a-reactive T cellsCompeting cells. Hypotheses on this target 1Competing cellsCorticotrophs. Hypotheses on this target 1CorticotrophsDendritic cells. Hypotheses on this target 1Dendritic cellsDifferentiated cells. Hypotheses on this target 1Differentiated cellsDll1-positive secretory progenitors. Hypotheses on this target 1Dll1-positive secretory progenitorsEpithelial progenitor cells. Hypotheses on this target 1Epithelial progenitor cellsFibroadipogenic progenitor cells. Hypotheses on this target 1Fibroadipogenic progenitor cellsFibroblasts. Hypotheses on this target 1FibroblastsGroup 3 innate lymphoid cells. Hypotheses on this target 1Group 3 innate lymphoid cellsHepatocytes. Hypotheses on this target 1HepatocytesIntestinal epithelial cells. Hypotheses on this target 1Intestinal epithelial cellsLgr5-positive stem cells. Hypotheses on this target 1Lgr5-positive stem cellsMast cells. Hypotheses on this target 1Mast cellsMature absorptive epithelial cells. Hypotheses on this target 1Mature absorptive epithelial cellsMedullary thymic epithelial cells. Hypotheses on this target 1Medullary thymic epithelial cellsMesenchymal stromal cells. Hypotheses on this target 1Mesenchymal stromal cellsMyeloid-biased long-term hematopoietic stem cells. Hypotheses on this target 1Myeloid-biased long-term hematopoietic stem cellsMyeloid–tissue hybrid cells. Hypotheses on this target 1Myeloid–tissue hybrid cellsMyofibroblasts. Hypotheses on this target 1MyofibroblastsNeutrophils. Hypotheses on this target 1NeutrophilsNK cells. Hypotheses on this target 1NK cellsReparative cells. Hypotheses on this target 1Reparative cellsSenescent osteogenic cells. Hypotheses on this target 1Senescent osteogenic cellsStromal cells. Hypotheses on this target 1Stromal cellsThymic epithelial cells. Hypotheses on this target 1Thymic epithelial cellsTumor-reactive T cells. Hypotheses on this target 1Tumor-reactive T cells
Tissues and matrixExtracellular matrix. Hypotheses on this target 11Extracellular matrixCollagen fibers. Hypotheses on this target 6Collagen fibersSkin tissue. Hypotheses on this target 4Skin tissueElastin–fibrillin network. Hypotheses on this target 3Elastin–fibrillin networkSubcutaneous adipose tissue. Hypotheses on this target 2Subcutaneous adipose tissueAntigen deposits. Hypotheses on this target 1Antigen depositsArterial resistance. Hypotheses on this target 1Arterial resistanceBasement membranes. Hypotheses on this target 1Basement membranesCell neighborhood geometry. Hypotheses on this target 1Cell neighborhood geometryCell surface geometry. Hypotheses on this target 1Cell surface geometryCorneocyte intercellular contacts. Hypotheses on this target 1Corneocyte intercellular contactsEpidermal mechanical stress. Hypotheses on this target 1Epidermal mechanical stressHyaluronan-proteoglycan matrix. Hypotheses on this target 1Hyaluronan-proteoglycan matrixMechanical prestress. Hypotheses on this target 1Mechanical prestressMotor units. Hypotheses on this target 1Motor unitsSensory axons. Hypotheses on this target 1Sensory axonsStratum corneum. Hypotheses on this target 1Stratum corneumStromal contacts. Hypotheses on this target 1Stromal contactsTendon tissue. Hypotheses on this target 1Tendon tissueTissue compression. Hypotheses on this target 1Tissue compressionTissue hydrostatic pressure. Hypotheses on this target 1Tissue hydrostatic pressureTissue mechanical relaxation spectrum. Hypotheses on this target 1Tissue mechanical relaxation spectrumVenous capacitance. Hypotheses on this target 1Venous capacitanceWet contact network between skin, clothing and bedding. Hypotheses on this target 1Wet contact network between skin, clothing and bedding
ProcessesEfferocytosis. Hypotheses on this target 8EfferocytosisSensory afferent activity. Hypotheses on this target 7Sensory afferent activityEpithelial barrier repair. Hypotheses on this target 6Epithelial barrier repairLipid peroxidation. Hypotheses on this target 6Lipid peroxidationProtein translation. Hypotheses on this target 6Protein translationCalcium phosphate mineral growth. Hypotheses on this target 4Calcium phosphate mineral growthInflammation resolution. Hypotheses on this target 4Inflammation resolutionInflammatory response. Hypotheses on this target 4Inflammatory responseVasomotor discharges. Hypotheses on this target 4Vasomotor dischargesActomyosin contraction. Hypotheses on this target 3Actomyosin contractionAntigen-receptor signaling. Hypotheses on this target 3Antigen-receptor signalingAntimicrobial immune functions. Hypotheses on this target 3Antimicrobial immune functionsCircadian phase distribution. Hypotheses on this target 3Circadian phase distributionMemory replay. Hypotheses on this target 3Memory replayMitophagy. Hypotheses on this target 3MitophagyScope inference. Hypotheses on this target 3Scope inferenceSleep continuity. Hypotheses on this target 3Sleep continuityThermal balance. Hypotheses on this target 3Thermal balanceTissue renewal timing. Hypotheses on this target 3Tissue renewal timingAntigen presentation. Hypotheses on this target 2Antigen presentationAntimicrobial memory. Hypotheses on this target 2Antimicrobial memoryAutophagy. Hypotheses on this target 2AutophagyBacteriophage replication. Hypotheses on this target 2Bacteriophage replicationBlood flow–sweat secretion synchrony. Hypotheses on this target 2Blood flow–sweat secretion synchronyBone remodeling. Hypotheses on this target 2Bone remodelingCell fusion. Hypotheses on this target 2Cell fusionCell proliferation. Hypotheses on this target 2Cell proliferationCell recruitment. Hypotheses on this target 2Cell recruitmentEndocrine fluctuations. Hypotheses on this target 2Endocrine fluctuationsFerroptosis. Hypotheses on this target 2FerroptosisGap junction communication. Hypotheses on this target 2Gap junction communicationOxidative capacity. Hypotheses on this target 2Oxidative capacityPolyploidization. Hypotheses on this target 2PolyploidizationPositional signaling. Hypotheses on this target 2Positional signalingTransepithelial water transport. Hypotheses on this target 2Transepithelial water transportAct-to-training handoff. Hypotheses on this target 1Act-to-training handoffActivator–inhibitor signaling. Hypotheses on this target 1Activator–inhibitor signalingAnabolism. Hypotheses on this target 1AnabolismAntibody–effector co-occupancy. Hypotheses on this target 1Antibody–effector co-occupancyAntigen cross-presentation. Hypotheses on this target 1Antigen cross-presentationAntigen processing. Hypotheses on this target 1Antigen processingAntimicrobial deployment–epithelial repair synchrony. Hypotheses on this target 1Antimicrobial deployment–epithelial repair synchronyAttention allocation. Hypotheses on this target 1Attention allocationAutomatic recommendation delivery. Hypotheses on this target 1Automatic recommendation deliveryAutonomic recovery. Hypotheses on this target 1Autonomic recoveryBacterial utilization of exogenous fatty acids. Hypotheses on this target 1Bacterial utilization of exogenous fatty acidsCalcium homeostasis. Hypotheses on this target 1Calcium homeostasisCalcium signal decoding. Hypotheses on this target 1Calcium signal decodingCandidate/source binding. Hypotheses on this target 1Candidate/source bindingCardiovagal baroreflex. Hypotheses on this target 1Cardiovagal baroreflexCargo-mediated pathogen transfer. Hypotheses on this target 1Cargo-mediated pathogen transferCathelicidin carbamylation. Hypotheses on this target 1Cathelicidin carbamylationCausal test-selection policy. Hypotheses on this target 1Causal test-selection policyCell competition. Hypotheses on this target 1Cell competitionCell-cycle entry. Hypotheses on this target 1Cell-cycle entryCell membrane repair. Hypotheses on this target 1Cell membrane repairCell survival signaling. Hypotheses on this target 1Cell survival signalingCellular–antibody response timing. Hypotheses on this target 1Cellular–antibody response timingCentrosome organization. Hypotheses on this target 1Centrosome organizationcGAS–STING signaling. Hypotheses on this target 1cGAS–STING signalingChromatin programme of chronic secretion. Hypotheses on this target 1Chromatin programme of chronic secretionCoagulation cascade. Hypotheses on this target 1Coagulation cascadeCollagen crosslinking. Hypotheses on this target 1Collagen crosslinkingColonocyte metabolism. Hypotheses on this target 1Colonocyte metabolismCommunicative planning. Hypotheses on this target 1Communicative planningCommunity-conditioned modification of reconstruction. Hypotheses on this target 1Community-conditioned modification of reconstructionCompeting action accessibility. Hypotheses on this target 1Competing action accessibilityCompetitive drug displacement. Hypotheses on this target 1Competitive drug displacementComplement cascade. Hypotheses on this target 1Complement cascadeConcurrent incompatible-update reconciliation. Hypotheses on this target 1Concurrent incompatible-update reconciliationConvention compatibility. Hypotheses on this target 1Convention compatibilityCue-to-intention binding. Hypotheses on this target 1Cue-to-intention bindingCulture-to-risk feedback. Hypotheses on this target 1Culture-to-risk feedbackCutaneous vasodilation. Hypotheses on this target 1Cutaneous vasodilationDefault-preserving meta-choice. Hypotheses on this target 1Default-preserving meta-choiceDNA integration. Hypotheses on this target 1DNA integrationDNA repair. Hypotheses on this target 1DNA repairDNA replication licensing. Hypotheses on this target 1DNA replication licensingEnactment-cost feedback. Hypotheses on this target 1Enactment-cost feedbackEndocrine–circadian phase relationship. Hypotheses on this target 1Endocrine–circadian phase relationshipEndothelium-dependent vasodilation. Hypotheses on this target 1Endothelium-dependent vasodilationEntity correspondence. Hypotheses on this target 1Entity correspondenceEpidermal sealing–dermal remodeling synchrony. Hypotheses on this target 1Epidermal sealing–dermal remodeling synchronyEpidermal turnover. Hypotheses on this target 1Epidermal turnoverER-selective autophagy. Hypotheses on this target 1ER-selective autophagyErythrocyte arrival timing. Hypotheses on this target 1Erythrocyte arrival timingExcitation–secretion coupling. Hypotheses on this target 1Excitation–secretion couplingExtracellular infectious particle stabilization. Hypotheses on this target 1Extracellular infectious particle stabilizationFailure detection and handover. Hypotheses on this target 1Failure detection and handoverFibrinolysis. Hypotheses on this target 1FibrinolysisGlutamine–glutamate cycle. Hypotheses on this target 1Glutamine–glutamate cycleGYS1-NONO condensation. Hypotheses on this target 1GYS1-NONO condensationHexosamine biosynthesis. Hypotheses on this target 1Hexosamine biosynthesisHistone export. Hypotheses on this target 1Histone exportHorizontal nuclear DNA transfer. Hypotheses on this target 1Horizontal nuclear DNA transferHost oxidant production. Hypotheses on this target 1Host oxidant productionIgG Fc glycosylation. Hypotheses on this target 1IgG Fc glycosylationImmune surveillance. Hypotheses on this target 1Immune surveillanceImmune target discrimination. Hypotheses on this target 1Immune target discriminationInstruction-scope conversion. Hypotheses on this target 1Instruction-scope conversionInterpretation switching. Hypotheses on this target 1Interpretation switchingIntracellular protein clearance. Hypotheses on this target 1Intracellular protein clearanceKeratinocyte polarity. Hypotheses on this target 1Keratinocyte polarityLymphocyte–APC contact timing. Hypotheses on this target 1Lymphocyte–APC contact timingLysosomal membrane permeabilization. Hypotheses on this target 1Lysosomal membrane permeabilizationLysosomal peptidoglycan degradation. Hypotheses on this target 1Lysosomal peptidoglycan degradationLysosome reformation. Hypotheses on this target 1Lysosome reformationMacromolecular crowding. Hypotheses on this target 1Macromolecular crowdingMeal–activity timing. Hypotheses on this target 1Meal–activity timingMechanical interference among lymphocytes. Hypotheses on this target 1Mechanical interference among lymphocytesMechanical load–mitosis timing. Hypotheses on this target 1Mechanical load–mitosis timingMechanical loading. Hypotheses on this target 1Mechanical loadingMechanoradical production. Hypotheses on this target 1Mechanoradical productionMental accounting. Hypotheses on this target 1Mental accountingMicrobial chemical defense. Hypotheses on this target 1Microbial chemical defenseMitochondrial fusion. Hypotheses on this target 1Mitochondrial fusionMitochondrial maintenance. Hypotheses on this target 1Mitochondrial maintenanceMitochondrial proton leak. Hypotheses on this target 1Mitochondrial proton leakMitochondrial transfer. Hypotheses on this target 1Mitochondrial transferMitosis. Hypotheses on this target 1MitosisMitotic entry in basal keratinocytes. Hypotheses on this target 1Mitotic entry in basal keratinocytesMitotic synchrony. Hypotheses on this target 1Mitotic synchronyMnemonic retention demand. Hypotheses on this target 1Mnemonic retention demandMuscle fiber adaptation. Hypotheses on this target 1Muscle fiber adaptationMutagenesis. Hypotheses on this target 1MutagenesisNeurogenic vasodilation. Hypotheses on this target 1Neurogenic vasodilationNeurokinin signaling. Hypotheses on this target 1Neurokinin signalingNeuronal secretion. Hypotheses on this target 1Neuronal secretionNF-κB activation. Hypotheses on this target 1NF-κB activationNitrogen-processing reaction network. Hypotheses on this target 1Nitrogen-processing reaction networkOrganelle maintenance. Hypotheses on this target 1Organelle maintenanceOxidative metabolism. Hypotheses on this target 1Oxidative metabolismParacrine signal–response synchrony. Hypotheses on this target 1Paracrine signal–response synchronyPartner retention and sorting. Hypotheses on this target 1Partner retention and sortingPathogen export. Hypotheses on this target 1Pathogen exportPeptide conjugation. Hypotheses on this target 1Peptide conjugationPeroxide clearance. Hypotheses on this target 1Peroxide clearancePlatelet adhesion. Hypotheses on this target 1Platelet adhesionPost-injury illness cascades. Hypotheses on this target 1Post-injury illness cascadesPreference construction. Hypotheses on this target 1Preference constructionPrimary cilium assembly. Hypotheses on this target 1Primary cilium assemblyProspective time allocation. Hypotheses on this target 1Prospective time allocationProtein carbamylation. Hypotheses on this target 1Protein carbamylationPublic commitment to cultural propositions. Hypotheses on this target 1Public commitment to cultural propositionsReceptor signal integration. Hypotheses on this target 1Receptor signal integrationReciprocal phase resetting. Hypotheses on this target 1Reciprocal phase resettingRegeneration–immune recognition timing. Hypotheses on this target 1Regeneration–immune recognition timingRegulatory-cell cytotoxicity. Hypotheses on this target 1Regulatory-cell cytotoxicityRelational memory. Hypotheses on this target 1Relational memoryRenal tubular reabsorption. Hypotheses on this target 1Renal tubular reabsorptionRibosome assembly. Hypotheses on this target 1Ribosome assemblyRNA splicing. Hypotheses on this target 1RNA splicingScratch contact. Hypotheses on this target 1Scratch contactScratch motor program. Hypotheses on this target 1Scratch motor programSemantic rewriting. Hypotheses on this target 1Semantic rewritingSensory integration. Hypotheses on this target 1Sensory integrationSkin adhesion. Hypotheses on this target 1Skin adhesionSkin barrier repair. Hypotheses on this target 1Skin barrier repairSolar radiation absorption. Hypotheses on this target 1Solar radiation absorptionSource-conditioned reconstruction. Hypotheses on this target 1Source-conditioned reconstructionSpatial coordination of ERK signaling. Hypotheses on this target 1Spatial coordination of ERK signalingStromal cell–matrix mechanical coupling. Hypotheses on this target 1Stromal cell–matrix mechanical couplingSweat evaporation. Hypotheses on this target 1Sweat evaporationThermoregulatory feedback. Hypotheses on this target 1Thermoregulatory feedbackTissue growth. Hypotheses on this target 1Tissue growthTissue renewal cycles. Hypotheses on this target 1Tissue renewal cyclesTissue repair. Hypotheses on this target 1Tissue repairTranscription. Hypotheses on this target 1TranscriptionTranscription-factor partnerships. Hypotheses on this target 1Transcription-factor partnershipsTranscription–replication conflicts. Hypotheses on this target 1Transcription–replication conflictsTranscriptional priming in estrogen-responsive cells. Hypotheses on this target 1Transcriptional priming in estrogen-responsive cellsTranscriptional repression. Hypotheses on this target 1Transcriptional repressionTransdermal drug absorption. Hypotheses on this target 1Transdermal drug absorptionTransmission timing. Hypotheses on this target 1Transmission timingtRNA queuosine modification. Hypotheses on this target 1tRNA queuosine modificationUbiquitin-dependent proteasomal degradation. Hypotheses on this target 1Ubiquitin-dependent proteasomal degradationVariant competition and selection. Hypotheses on this target 1Variant competition and selectionVascular obstruction. Hypotheses on this target 1Vascular obstructionExtracellular vesicle clearance. Hypotheses on this target 1Extracellular vesicle clearance
Microbial communitiesGut microbiota. Hypotheses on this target 3Gut microbiotaBacterial pathogens. Hypotheses on this target 1Bacterial pathogens
MeasurementsCultural transmission mechanism classification. Hypotheses on this target 9Cultural transmission mechanism classificationMenopause syndrome classification. Hypotheses on this target 5Menopause syndrome classificationSweat secretory response. Hypotheses on this target 5Sweat secretory responseCircadian phase. Hypotheses on this target 2Circadian phaseCognitive performance measurements. Hypotheses on this target 2Cognitive performance measurementsNyquist stability boundary. Hypotheses on this target 2Nyquist stability boundaryRecovery status classification. Hypotheses on this target 2Recovery status classificationAntibody neutralizing activity. Hypotheses on this target 1Antibody neutralizing activityApplied shear load. Hypotheses on this target 1Applied shear loadCausal-binding accessibility. Hypotheses on this target 1Causal-binding accessibilityClone size measurement. Hypotheses on this target 1Clone size measurementContractile exit assessment. Hypotheses on this target 1Contractile exit assessmentFunctional performance measurements. Hypotheses on this target 1Functional performance measurementsInvasion measurement. Hypotheses on this target 1Invasion measurementMitotically reactivatable infected cell count. Hypotheses on this target 1Mitotically reactivatable infected cell countmt-Keima signal. Hypotheses on this target 1mt-Keima signalOptical oxygen saturation estimate. Hypotheses on this target 1Optical oxygen saturation estimatePerfusion measurements. Hypotheses on this target 1Perfusion measurementsSemantic coding. Hypotheses on this target 1Semantic codingSkin ageing index. Hypotheses on this target 1Skin ageing indexSkin microdamage classification. Hypotheses on this target 1Skin microdamage classificationSkin redness. Hypotheses on this target 1Skin rednessSkin water evaporation measurement. Hypotheses on this target 1Skin water evaporation measurementTarget-specific immune response measurements. Hypotheses on this target 1Target-specific immune response measurementsTreatment response classification. Hypotheses on this target 1Treatment response classificationViable pathogen burden. Hypotheses on this target 1Viable pathogen burden

Solid and named: the targets of this hypothesis

Explore in depth

The logic

The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.

The descent, in plain words

Damage from immune cells might persist because material they release keeps attacking tissue after the cells themselves could have been removed. The unexpected move is to distinguish clearing whole cells from clearing the tiny particles they leave behind: blocking one might still allow the other to support recovery. This is a proposal generated by the pipeline, not a measured explanation of benefits across organs.

The proposed mechanism, link by link
  1. release small particles carrying on their surfaces.
  2. is proposed to leave able to cut tissue proteins while restricting access by its large natural .
  3. suppression is proposed to switch from inadequate particle to restored , while whole- remains blocked.
  4. would remove the particles together with their protected, active .
  5. Less particle-bound would mean less continuing tissue damage.
  6. Reduced continuing damage would leave several body systems with less .
A picture for it

A cutting blade sits behind a crowded fence: material can still reach its edge, but a bulky safety cover cannot fit through. Taking away the whole assembly removes the exposed cutting hazard.

Where the picture breaks: , and particle surfaces move and interact chemically rather than behaving like rigid tools. The proposal's model assumes randomly placed surface obstacles and mainly physical obstruction; electrical interactions, surface curvature and differences in how tightly bind require separate checks.

  1. Master questionstep 01 of 04

    Aging processes may reinforce one another, so acting on a shared cause could benefit several body systems at once.

    Rests on: The goal explicitly seeks a shared causal link whose treatment could produce several benefits together.

    Stated in the chain
  2. Goal pillarstep 02 of 04

    Recovery should resist becoming stuck in a damaged state.

    Rests on: The search for a shared cause is narrowed to the persistence of damage after recovery should have occurred.

    Assumption

    The narrowing assumes that becoming stuck in a damaged state is a useful shared target across aging systems. The master question does not supply that connection.

  3. Gap questionstep 03 of 04

    Benefits across body systems might survive suppression of prostaglandin E2 receptor type 2, or , a cell receptor for an inflammatory signal, even if removal of , a type of immune cell, cannot recover. Such persistence would challenge the claim that clearing these cells is necessary for the benefit.

    Rests on: The recovery theme is narrowed to a particular receptor and a particular cell-removal process.

    Leap

    The preceding stage supplies no connection between persistent damage, suppression and removal. The supplied sources also do not establish that suppression produces the proposed benefits across systems.

  4. Hypothesisstep 04 of 04

    , an released by that cuts proteins, is proposed to sustain damage while attached to , small membrane-enclosed particles outside cells. Its position would let it reach tissue proteins while shielding it from , a natural protein that inhibits . suppression is proposed to restore of these particles by , immune cells that engulf cells and material, even while of whole remains blocked. Removing the particles would then reduce the loss of function that remains after injury.S1S2S3

    Rests on: The preceding question supplies the distinction to resolve: whether benefit can persist when whole-cell removal is blocked. S1, a 2023 study in American Journal of Physiology. Lung Cellular and Molecular Physiology using a mouse model of , a lung disease involving damaged air sacs, reports that detaching from makes it susceptible to its natural again; it does not establish -dependent particle or recovery across organs. S2, in JCI Insight in 2022, reports measurement of surface on mouse airway ; it does not establish protection from the or the proposed recovery route. The supplied abstract from S3, in in 2025, reports more -rich with increased surface in blood from people deficient in ; it does not establish shielding, particle or functional benefit. These observations support the proposed material being targeted, while the -to--to-recovery sequence remains a hypothesis.

    Supported by literature

What is carried, and what is not. The screened sources speak to two of the six listed links: surface on particles and protection associated with surface attachment, with direct support for the latter coming from S1. None establishes the complete sequence from suppression through particle removal to sustained recovery across organs.S1

Where the reasoning is carried by something unstated · 2
  • Goal pillar. The narrowing assumes that becoming stuck in a damaged state is a useful shared target across aging systems. The master question does not supply that connection.
  • Gap question. The preceding stage supplies no connection between persistent damage, suppression and removal. The supplied sources also do not establish that suppression produces the proposed benefits across systems. Establish the missing link before relying on this step.
How a result here could mislead · 3
  • Benefit that survives blocked could be credited to particle merely because fewer harmful particles are present. Fewer particles could instead reflect reduced production, while benefit could come from the rivals' proposed protective particles, damage-resistant tissue cells or inflammation-ending signals; early improvement in one organ could also conceal later damage elsewhere. What closes it: Whole- must remain demonstrably blocked, and and disappearance of the -bearing particles must be measured alongside their production and activity. Functions of the affected organs require separate follow-up over a period fixed in advance. The supplied specification gives no duration or criterion for sustained benefit.
  • Loss of benefit after returning particles with active could be attributed to that even if preparation or inactivation also changes other particle contents, particle integrity or their . Equal particle numbers alone would not resolve that ambiguity. What closes it: The active and inactive preparations must be comparable in particle amount, integrity, other contents and , with the difference in activity verified. The proposal includes equal particle numbers and inactive as a comparison, but does not specify these additional checks.
  • A smaller working better could be read as evidence that excludes larger , although electrical interactions or differences in binding could produce the same ranking. Matching inhibition of free does not by itself establish the proposed geometric explanation. What closes it: The specified comparison against free and the predicted disappearance of the size effect after detachment are required together. Electrical effects, surface curvature and binding must also be assessed, as the proposal acknowledges; its remains an idealization to test.

What would make this wrong. The proposed explanation would fail if sustained benefit across the measured organs persisted under verified blockade of whole- while the amount and tissue-damaging activity of -bearing particles remained unchanged. Its distinguishing prediction would also fail if returning verified active particles did not remove the benefit, or if otherwise comparable particles with inactive removed it equally. Either outcome would undermine this particle- explanation without establishing which rival is correct.

What it would change. If the mechanism held, a shared target for recovery could be the harmful material immune cells leave outside themselves, even when removal of the cells is unnecessary for benefit. Work on a single intervention for several aging systems would then have to distinguish of whole cells from of their damaging products. Even a positive result would leave effects on aging and lifespan unestablished: the supplied test outline specifies no species, follow-up duration or operational measure of lasting functional loss.

Sources read · 3

6 literature searches, 2 full texts, 1 abstract-only; 3 source(s) assessed against this question using the available text. A bounded search is not evidence of absence.

S1Partly answers it

Therapeutic effect of two strategies directed at disruption of pathogenic neutrophil extracellular vesicles in a murine emphysema model. · American journal of physiology. Lung cellular and molecular physiology · 2023

“Protamine sulfate facilitates the removal of neutrophil elastase (NE) from the surface of extracellular vesicles from activated neutrophils. This “free” NE is no longer protected from inhibition by its endogenous anti-protease, α-1-anti-trypsin.”

Does not settle: Источник изучает протамин-сульфат и ингибитор связывания в модели эмфиземы у мышей. Он не исследует подавление EP2, захват везикул макрофагами, блокаду поглощения целых нейтрофилов, удаление носителей протеазы или остаточный дефицит SPV_6.

S2Partly answers it

An in vivo model for extracellular vesicle-induced emphysema. · JCI insight · 2022

“( D ) Quantification of surface NE on airway EVs of LPS- and saline-treated mice by bead-based flow cytometric analysis.”

Does not settle: Фрагмент подтверждает измерение поверхностной нейтрофильной эластазы на везикулах дыхательных путей у мышей после ЛПС, но не устанавливает защиту этой эластазы от альфа-1-антитрипсина, роль EP2, захват везикул макрофагами, блокаду поглощения нейтрофилов или функциональный дефицит SPV_6.

S3Partly answers itAbstract only

Neutrophil-derived extracellular vesicles in the plasma of alpha-1 antitrypsin deficient individuals reveal pro-inflammatory metabolic and transcriptomic signatures. · Extracellular vesicle · 2025

“Isolation and characterization of neutrophil-derived extracellular vesicles (EV) demonstrated an increased plasma burden of neutrophil elastase (NE)-rich EV with elevated surface-bound NE.”

Does not settle: It does not establish protection of vesicle-bound elastase from alpha-1 antitrypsin, EP2-dependent macrophage uptake, effects of blocking neutrophil engulfment, tissue damage, or improvement of SPV_6 functional deficit.

The gap this hypothesis explains

Two live hypotheses pull in opposite directions here, and the field has not chosen between them.

Does suppressing a cell signal still benefit several body systems when improved removal of worn-out immune cells is blocked?

Original wording · exactly as the pipeline generated it
The gap question, as the engine wrote it

Сохранится ли польза подавления , если избирательно воспрепятствовать восстановлению удаления , и опровергнет ли такой результат как общее ?

What this question is asking

The question asks whether improved removal of worn-out , a type of immune cell, is necessary for benefits across several body systems. The intervention suppresses signaling through E prostanoid receptor subtype 2 () in tissue-resident , immune cells that live in tissues and remove cellular material. The comparison is between suppression that allows removal to improve and the same suppression with that improvement selectively prevented. The question assumes that suppression improves both removal and several aspects of health in aged mice, while treating removal as a possible shared cause of those benefits. It also asks whether benefits persisting when improved removal is blocked would disprove that proposed causal explanation.

What the terms mean
E prostanoid receptor subtype 2 (EP2)
A cell receptor through which prostaglandin E2 sends signals. The question concerns reducing its signaling in tissue-resident ; the supplied sources report different consequences of this signaling in different settings.
Prostaglandin E2
A signaling molecule that acts through receptors including . In the supplied sources, its signaling is linked to increased removal of dying cells, impaired bacterial killing, and protection against scarring, so its effects cannot be reduced to a single beneficial or harmful role.
Neutrophils
A type of immune cell. The question concerns removal of worn-out , rather than their production or every function they perform.
Senescent neutrophils
The aged or worn-out named in S1's title. The supplied material does not specify how that state was identified or whether it matches the dying-cell states studied in the other sources.
Tissue-resident macrophages
Immune cells that reside in tissues and can ingest cells and other material. They are the cells whose signaling was reduced in S1.
Clearance
Removal of cells or other material from a tissue. Here, the proposed causal step is improved removal of ; reduced accumulation alone would not specify how that reduction occurred.
Programmed cell death
An organized process through which cells die. The dying cells ingested in S6 should not automatically be treated as equivalent to every described as senescent in S1.
Mitochondrial fitness
The functional condition of mitochondria, structures within cells involved in supplying usable energy. S1 reports preservation of this condition but the supplied quotation does not specify its measurement.
Inflammation
A tissue and immune response to injury or threats. Body-wide inflammation is one of S1's reported outcomes, while the question asks whether improved cell removal explains its reduction.
Cognitive decline and frailty
Cognitive decline means worsening abilities such as memory and thinking; frailty means increased vulnerability associated with reduced physical reserves. Both are outcomes named in S1, but their measurement criteria are not supplied.
Hydrogen peroxide
A reactive chemical involved in the bacterial-killing mechanism described in S5. That source links reduced production of it to impaired bacterial killing.
Scarring
Formation of fibrous tissue, also called fibrosis. S8 concerns a possible loss of protection against this process in the uterine lining.
Selective prevention
The question's assumed ability to stop improvement in removal while keeping suppression effective and avoiding other changes that could explain the outcomes. The supplied sources do not establish that this separation was achieved.
Necessary and sufficient causes
A necessary step must occur for a particular benefit to occur under the stated conditions. A sufficient step can produce that benefit on its own; showing necessity does not establish sufficiency.
What the question takes for granted
Premise only partly supported
Suppressing improves and condition in aged mice and produces benefits across several body systems, with proposed as their common causal link.

are immune cells, and tissue-resident are cells that can remove them as they become worn out. The assumption is that reducing signaling through a receptor on these improves their condition and removal work, alongside benefits elsewhere in the body. If established, that connection would provide the starting point for asking whether improved removal is required for those benefits.

S1 directly reports that reducing signaling in aged mice preserved mitochondrial fitness and prevented several adverse outcomes. Its title identifies restored of senescent as the subject, but the supplied abstract quotation does not detail that result or establish its necessity for the broader benefits. S6 reports increased of dying cells following activation in another setting, so a general claim that less signaling necessarily improves is not supported. None of the supplied passages establishes as the necessary common cause.S1S6

The same question asked without the part nothing read establishes:

  • In aged mice, do the benefits of reducing signaling persist when improved removal is selectively prevented?
  • Which benefits of reducing signaling in aged mice require improved removal?
What turns on the answer
  • Benefits persist across systems If improved removal were genuinely prevented while receptor suppression remained effective, persistent benefits would mean that this improvement was not necessary for those measured benefits under those conditions. That would challenge restoration as their required common cause, while leaving possible contributions from existing or other settings unresolved.
  • Benefits disappear across systems Under the question's assumption of selective interference, losing the benefits would support a requirement for improved removal. It would not by itself establish that removal is the sole cause or that improving removal alone is sufficient to produce those benefits.
  • Some benefits persist and others disappear Under the same selectivity assumption, the outcomes would differ in their dependence on improved removal. restoration could then explain some benefits without serving as a necessary common link for every measured system.
Why it matters

The proposed chain runs from reduced receptor signaling to improved removal of worn-out immune cells, then to less inflammation and better function across several body systems. If improved removal is necessary, blocking that improvement would interrupt the chain despite continued receptor suppression. If benefits persist, the proposed explanation would need to distinguish benefits that require improved removal from benefits that do not. Mistaking an accompanying change for a necessary cause would misidentify why the intervention works; assuming that receptor suppression always helps would also overlook the opposing effects reported in other biological settings.

What is already established

Подавление улучшает и состояние у мышей, RL-1; необходимость для общего устойчивого эффекта отдельно не установлена.

What would have to be true

Воспаление и функции возвращаются в заданные диапазоны за дни или недели; повторные нагрузки сохраняют восстановление нескольких систем месяцами.

What is missing

Требуется разорвать предполагаемую и проверить, исчезает ли польза при сохранённом воздействии на .

The mechanism it proposes

The engine's own statement of the hypothesis, in full.

повреждение поддерживает , закреплённая на поверхности мелких и пространственно защищённая от крупного природного . Подавление предположительно восстанавливает этих , даже когда целых остаётся заблокированным. представляет доступная тканевым белкам, но защищённая от . Удаление её носителей должно уменьшать SPV_6. Сохранение пользы при блокаде в таком случае опровергнет необходимость удаления целых клеток, сохранив причинную роль от их продуктов.

Where the idea comes from

The hypothesis borrows a result from another field. This is what it borrows, and from where.

и ; с . Для локально плоского участка поверхности доля доступных подходов к задаётся приближением f(r)=exp[-σπ(a+r)^2], а наблюдаемая k_on,obs(r)=k_on,free(r)f(r). Здесь r обозначает ; a обозначает радиус поверхностного препятствия; σ обозначает число препятствий на единицу площади ; f обозначает долю геометрически доступных подходов; k_on,free обозначает с открытой ; k_on,obs обозначает с поверхностной . π является геометрической константой. Это проверяемая идеализация, предполагающая случайное размещение препятствий и преимущественно . , кривизну и проверяют отдельно.

Testing and possible results

The prediction that would tell it apart

A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.

При блокаде целых эффект подавления сохраняется только при снижении количества с активной . Возврат таких устраняет пользу; равное количество с этого не делает. При одинаковой активности против малый подавляет везикулярную и восстанавливает функции эффективнее крупного . После отделения от поверхности размерная зависимость исчезает.

States a measurable outcome; comparing rivals needs more conditions. The prediction specifies observable qualitative contrasts between active and inactivated elastase vesicles, different inhibitor sizes, and disappearance of size dependence after elastase detachment. No rival prediction is supplied. Only a bench experiment would settle it.

What testing it would take

The engine's own read on whether this is testable with methods that already exist.

на нейтрофильных , устойчивая к , экспериментально описана. Доступны , измерение и сравнение . Восстановление удаления именно этой фракции после подавления ещё требуется показать.

Other explanations

Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.

This hypothesis predicts

При блокаде целых эффект подавления сохраняется только при снижении количества с активной . Возврат таких устраняет пользу; равное количество с этого не делает. При одинаковой активности против малый подавляет везикулярную и восстанавливает функции эффективнее крупного . После отделения от поверхности размерная зависимость исчезает.

  • What would separate them

    Delaying neutrophil uptake may preserve vesicle-mediated complement inhibition predicts: При подтверждённом подавлении и одинаковом исходном повреждении блокада дополнительно улучшает восстановление мышцы, сердца и лёгких. Этот дополнительный выигрыш исчезает при и возвращается после введения очищенных . Напротив, независимое ускорение удаления при сохранённой блокаде ухудшает восстановление, если происходит до образования защитных . Простое сохранение пользы при блокаде для подтверждения этой гипотезы недостаточно.

  • What would separate them

    Suppressing a prostaglandin receptor may curb ferroptosis through itaconate predicts: При подавлении и блокаде функции улучшаются на фоне сопоставимых количества , активности и внеклеточной . Одновременно снижаются и гибель . устраняет этот выигрыш; прямое подавление в восстанавливает его при продолжающейся блокаде . Отсутствие увеличения после подавления опровергает предложенную связь.

  • What would separate them

    Shared lipid synthesis in neutrophils and platelets may limit tissue damage predicts: Польза подавления сохраняется при блокаде и сопровождается усилением образования из нейтрофильного . устраняет этот эффект при сохранённых количестве , активности на и . Введение соответствующего продукта восстанавливает функции. Отсутствие зависимости от тромбоцитарного при подтверждённом его выключении опровергает гипотезу.

  • What would separate them

    Neutrophil movement may shift damage between organs and mimic lasting recovery predicts: После подавления на фоне блокады исчезают из исходной ткани, но сохраняются в крови и обнаруживаются в удалённых органах. Раннее улучшение мышцы сопровождается отсроченным ухудшением лёгочной или сердечной функции после повторной обычной нагрузки. За заранее заданный период наблюдения согласованного функционального выигрыша трёх систем нет. Подтверждённое улучшение всех трёх систем на протяжении месяцев при отсутствии переноса опровергает эту гипотезу.

What stands behind it

Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.

This hypothesis states no figure and cites no study, so there is nothing here to trace.

CitationsCites nothingFiguresnone statedPredictionStates a measurable outcome; comparing rivals needs more conditionsTo refuteOnly a bench experiment would settle it

What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.

0 citation handles extracted; 1 Europe PMC search run; 0 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.